The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs

作者: Jing Zhang , Frank Visser , Karen M. King , Stephen A. Baldwin , James D. Young

DOI: 10.1007/S10555-007-9044-4

关键词:

摘要: Nucleoside analogs are important components of treatment regimens for various malignancies. Nucleoside-specific membrane transporters mediate plasma permeation physiologic nucleosides and most nucleoside analogs, which the initial event is cellular conversion to active agents. Understanding roles in drug toxicity resistance will provide opportunities potentiating anticancer efficacy avoiding resistance. Because transportability a possible determinant many transporter abundance might be prognostic marker assess Elucidation structural determinants interaction with proteins as well features required permeant translocation lead “transportability guidelines” rational design therapeutic application drugs. It should eventually develop clinical assays that predict sensitivity and/or anti-cancer drugs thus identify those patient populations likely benefit from optimal analog treatments. This review discusses recent results structure/function studies human transporters, role transport processes cytotoxicity several strategies improve transporter-related effects analogs.

参考文章(206)
Antonio FELIPE, Raquel VALDES, Belén del SANTO, Jorge LLOBERAS, Javier CASADO, Marçal PASTOR-ANGLADA, Na+-dependent nucleoside transport in liver: two different isoforms from the same gene family are expressed in liver cells Biochemical Journal. ,vol. 330, pp. 997- 1001 ,(1998) , 10.1042/BJ3300997
R. D. Issels, L. Schulz, William K Plunkett, V. Heinemann, Gemcitabine: a modulator of intracellular nucleotide and deoxynucleotide metabolism. Seminars in Oncology. ,vol. 22, pp. 11- 18 ,(1995)
Balcerzak Sp, Kopecky Kj, Hutton Jj, Grever Mr, Greenberg Br, Talley R, Von Hoff Dd, Coltman Ca, Files Jc, Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia. Nouvelle revue française d'hématologie. ,vol. 30, pp. 457- 459 ,(1988)
Marilyn L. Clarke, John R. Mackey, Stephen A. Baldwin, James D. Young, Carol E. Cass, The role of membrane transporters in cellular resistance to anticancer nucleoside drugs. Cancer treatment and research. ,vol. 112, pp. 27- 47 ,(2002) , 10.1007/978-1-4615-1173-1_2
Wei Kong, Karen Engel, Joanne Wang, (Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) Mammalian Nucleoside Transporters Current Drug Metabolism. ,vol. 5, pp. 63- 84 ,(2004) , 10.2174/1389200043489162
Lara M. Mangravite, Kathleen M. Giacomini, Sorting of rat SPNT in renal epithelium is independent of N-glycosylation. Pharmaceutical Research. ,vol. 20, pp. 319- 323 ,(2003) , 10.1023/A:1022247826750
Schmoll Hj, Dempke W, Büchele T, Grothey A, Where do we stand with 5-fluorouracil? Seminars in Oncology. ,vol. 26, pp. 589- 605 ,(1999)
Alain Marty, Erwin Neher, Tight-Seal Whole-Cell Recording Springer, Boston, MA. pp. 107- 122 ,(1983) , 10.1007/978-1-4615-7858-1_7
Marci E. Schaner, Juan Wang, Shoshana Zevin, Karin M. Gerstin, Kathleen M. Giacomini, Transient expression of a purine-selective nucleoside transporter (SPNTint) in a human cell line (HeLa). Pharmaceutical Research. ,vol. 14, pp. 1316- 1321 ,(1997) , 10.1023/A:1012148016794
Kaspar P Locher, Randal B Bass, Douglas C Rees, Breaching the Barrier Science. ,vol. 301, pp. 603- 604 ,(2003) , 10.1126/SCIENCE.1088621